Navigation Links


Anesiva in Medical News

Anesiva Announces Going Concern Opinion and Nasdaq Notice

...tements or to its annual report on Form 10-K. anesiva also announced that it received a letter on March ...e Nasdaq rules upon which it is based. About anesiva Anesiva, Inc. seeks to be a leader in the deve...c, moderate-to-severe pain. In December 2008, anesiva announced that a Phase 3 clinical trial of Adlea a...

Anesiva Announces Planned Rights Offering

...uld if fully subscribed, produce gross proceeds to anesiva of an aggregate principal amount of $3,000,000. anesiva will be distributing non-transferable rights to su...amount of notes, for each share of common stock of anesiva owned as of 5:00 p.m., Pacific time, on the Record...

Child Life Council Urges Parents to Think Ahead to Ease Child's Hospital Visit

... Washington, D.C., 2006. (2) Wong DL and Baker CM. Pain in Children: Comparison of Assessment Scales. Pediatric Nursing. 1988;14:9-17. (3) anesiva data on file. (4) Zempsky WT, Bean-Lijewski J, Kauffman RE et al. Needlefree Powder Lidocaine Delivery System Provides Rapid Effective Analgesia...

Anesiva Announces May 22, 2008 Presentation at Citi Investment Research Global HealthCare Conference

...sure adequate time for any software download that may be necessary. About anesiva and its Diverse Pipeline of Pain Products Anesiva, Inc. is a late-stage b...nical trials for site-specific, acute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...

Anesiva and Sigma-Tau Announce Exclusive Marketing and Distribution Agreement for Zingo(TM) in Six European Countries

...tive Officer at Sigma-Tau. The agreement between anesiva and Sigma-Tau includes an upfront payment to anesiva and transfer price, as well as milestone payments;...u, please visit http://www.sigma-tau.it . About anesiva and its Pipeline of Pain Products Anesiva, Inc. ...

Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)

...clusion on hospital formularies and sales uptake." anesiva and Sagent have a co-promotion agreement for Zingo in the United States. The two anesiva sales directors are Joseph Levato and David Randal...ng new products and exceeding goals. Dave comes to anesiva from Elan Corporation where he spent 13 years, the...

Anesiva Announces Upcoming Webcasts and Conference Participation

...nsure adequate time for any software download that may be necessary. About anesiva and its Diverse Portfolio of Pain Products Anesiva, Inc. is a late-stage b...erous mid-stage clinical trials for site-specific, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...

Anesiva to Announce Third Quarter 2007 Financial Results and Host Webcast Conference Call on November 1, 2007

...ntil the company's next quarterly financial results conference call. About anesiva and its Diverse Pipeline of Pain Products Anesiva, Inc. is a late-stage bi...erous mid-stage clinical trials for site-specific, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...

Anesiva to Present at BIO InvestorForum on October 11, 2007

...nsure adequate time for any software download that may be necessary. About anesiva and its Diverse Portfolio of Pain Products Anesiva, Inc. is a late-stage b...erous mid-stage clinical trials for site-specific, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...

Anesiva to Unveil Zingo(TM) Commercialization Plans

... in physicians' offices and clinical laboratories. anesiva also recently completed enrollment of a Phase 3 tr... the label beyond the pediatric population. About anesiva and its Diverse Portfolio of Pain Products Anesiv...trials for site-specific, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more info...
Anesiva in Medical Technology

Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication

...A deadlines. As announced in November 2008, anesiva ceased Zingo commercial activities to focus on the...ment of acute pain following orthopedic surgeries. anesiva is seeking to license Zingo as well as the underly...echnology and intellectual property. About anesiva Anesiva, Inc. seeks to be a leader in the d...

Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring

... is most restricted," said William Houghton, M.D., anesiva senior vice president and chief medical officer. "...hour analgesic measure as its primary endpoint." anesiva has determined that it will cease further commitme...n China to discuss the future of the relationship. anesiva will restructure, suspend or cancel Zingo distribu...

Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company

... its Adlea registration strategy. "Since joining anesiva in mid-June, I have conducted an extensive review ...imately $0.7 million in the third quarter of 2008. anesiva believes that the restructuring and other cost red... million per year as compared to current levels. anesiva also provided the following updates directly relat...

Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery

...nd. The trial is designed to enroll 74 patients. anesiva announced approval of its investigational new drug...ar in patients receiving Adlea or placebo. About anesiva and its Diverse Pipeline of Pain Products Anesiv...fic, acute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more info...

Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application

...gement of acute pain following orthopedic surgery. anesiva plans to initiate a Phase 2 clinical trial of Adle...ar in patients receiving Adlea or placebo. About anesiva and its Diverse Pipeline of Pain Products Anesiv...novel pharmaceutical products for pain management. anesiva has one FDA-approved product, Zingo(TM), for the r...

Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics

...ians' offices and clinical laboratories. In March, anesiva submitted a supplemental New Drug Application with...l IV insertions and blood draws in adults. About anesiva and its Diverse Pipeline of Pain Products Anesiv...trials for site-specific, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more info...

Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement

...acement surgery, is underway. In September 2007, anesiva initiated a multicenter, randomized, double-blind,...f pain management following orthopedic surgery." anesiva has previously completed Phase 1 and 2 trials of A...ed with moderate to severe osteoarthritis. About anesiva and its Diverse Pipeline of Pain Products Anesiv...

Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy

...aseline over the twelve week study period. About anesiva and its Diverse Pipeline of Pain Products Anesiv...cific, acute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more info... Form 10-K for the year ended December 31, 2007. anesiva undertakes no obligation and does not intend to up...

Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults

...d to be well tolerated in this patient population. anesiva plans to file a supplemental new drug application ...mercially available in the second quarter of 2008. anesiva recently announced it will hire a sales force of t... to support the launch of Zingo for pediatric use. anesiva also announced a co-promotion collaboration with S...

Anesiva Defines Regulatory Pathway for Adlea with FDA

...mg in total knee arthroplasty) will be evaluated. anesiva is focused on two lead indications for Adlea: mana... another trial in total hip replacement surgeries. anesiva expects to initiate the following additional trial...s to go home the same day of their surgery. About anesiva and its Diverse Portfolio of Pain Products Anesiv...
Anesiva in Biological Technology

Anesiva Receives NASDAQ Delisting Staff Determination Letter

...Market LLC ("NASDAQ") on March 27, 2009, informing anesiva that it was not in compliance with Marketplace Rul... NASDAQ Global Market. On July 17, 2009, anesiva received a letter from NASDAQ notifying anesiva that based on NASDAQ's further review of...

Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

...elopments, we look forward to rebuilding value for anesiva through our virtual model, and through active part...ures will be done each year by 2030. About anesiva Anesiva, Inc. seeks to be a leader in the ...cute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more info...

Anesiva Announces Conference Call and Webcast to Discuss Updates to Corporate Strategy and Milestones

...tern time (8:30 am Pacific time). During the call, anesiva management will update its corporate strategy and ...arterly financial results conference call. About anesiva and its Diverse Pipeline of Pain Products Anesiv...fic, acute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more info...

Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer

...inical and regulatory functions. "Bill brings to anesiva deep commercial and product development expertise ...ity of Sydney (Australia). "I am pleased to join anesiva at this exciting time, with Zingo on the U.S. mark...uild a leading pain management franchise." About anesiva and its Pipeline of Pain Products Anesiva, Inc. ...

Anesiva to Present at BioCentury Newsmakers Conference on September 4, 2008

...sure adequate time for any software download that may be necessary. About anesiva and its Diverse Pipeline of Pain Products Anesiva, Inc. is a late-stage b...cal trials for site-specific, acute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...

Anesiva Announces Second Quarter 2008 Financial Results and Update

...08 second quarter marked a significant advance for anesiva as we introduced Zingo(TM) in the U.S. pediatric h...ing the Zingo U.S. commercial launch in late June, anesiva began supplying hospitals in its target pediat...ivotal Phase 3 pediatric trials of Zingo. -- anesiva signed an exclusive Zingo licensing and distributi...

Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children

...edures are performed annually in U.S. hospitals. anesiva and its co-promotion partner Sagent Pharmaceutical...s and meet anticipated increasing market demand. anesiva intends to grow a global brand for Zingo through g...agreements in other major markets are in progress. anesiva also has established a joint venture in China for ...

Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors

...igned as chief executive officer and member of the anesiva board to pursue other business interests, while re...he company. "Michael is the ideal person to lead anesiva as it transitions from a drug development company ...ngo(TM) and Adlea(TM) Phase 3 clinical milestones, anesiva is poised to become a leader in the development an...

Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program

...s, and asthma. Under the terms of the agreement, anesiva will receive an upfront license fee, with addition...o $114 million if two products are commercialized. anesiva would also be entitled to royalty payments upon su...g in the U.S. in the second half of 2009." About anesiva and its Pipeline of Pain Products Anesiva, Inc. ...

FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults

...ng information, go to http://www.anesiva.com/img/ZingoPackage.pdf About anesiva and its Diverse Pipeline of Pain Products Anesiva, Inc. is a late-stage b...nical trials for site-specific, acute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...
Other TagsBioticBioticBioticBlottingBlotting
(Date:12/4/2009)...ican Association of Homes and Services for the Agi...the Community Living and Supportive Services (CLAS...gislation . The CLASS provisions are essential for...ties and their caregivers. ,, We urge the Senate ...t affordable to care for families and caregivers. ...
(Date:12/4/2009)...The large, two-day free health clinic sponsored by...n Kansas City on Wednesday and Thursday is not jus...d and has not seen a doctor recently. All particip...primary care. ,, "Many people who attended the th... Houston, New Orleans and Little Rock found out th...
(Date:12/4/2009)...Pamela Bowen, Chief Information Officer at Crescen...Chief Innovation Officer" Appy Award for transform...mputing. Appy Award recipients are nominated based...e Force.com platform in bringing new levels of cus...service, support or IT organizations. ,, "It is a...
(Date:12/4/2009)...ponse to the U.S. Justice Department Drug Enforcem...oxymethyltestosterone, and 19-nor-4,9(10)-androsta...olled Substances Act (CSA), John Gay, executive di... (NPA), the oldest and largest trade association ...y supplements and other natural products, issued t...
(Date:12/4/2009)...dy shows that muscle cells grown in the lab can re...rly. The work, performed in dogs and rats, might u... as gastric reflux and fecal incontinence. , This...hich are the bands of muscle that separate the maj...these areas can cause gastrointestinal esophageal ...
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4
(Date:12/2/2009)...exposed to secondhand cigarette smoke have an incr... even if they never smoked. , Results of this st...ers & Prevention , a journal of the American Assoc...obacco focus in the December issue. , This year ...ed with lung cancer; more than 159,000 will die fr...
(Date:12/2/2009)... results strengthen the evidence that people who s... increased risk for developing colorectal cancer, ...This provides one more reason not to smoke, or to ...ael J. Thun, M.D., M.S., vice president emeritus, ...ican Cancer Society. "Colorectal cancer should be ...
(Date:12/2/2009)...o smoke their first cigarette within minutes after...by-product of nicotine when processed by the body,...umber of cigarettes smoked. , "Since cotinine ...our results suggest that smokers who smoke immedia...ng cancer," said researcher Joshua E. Muscat, Ph.D...
Breaking Biology News(10 mins):Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Cigarette smoking increases colorectal cancer risk 2Increased nicotine levels detected in those who light-up earlier 2Regence BlueShield of Idaho Announces Executive Changes 53303 1Regence BlueShield of Idaho Announces Executive Changes 53303 2Regence BlueShield of Idaho Announces Executive Changes 53303 3American Association for Homecare Supports Crackdown on Medicare Scammers in Houston Boston New York Louisiana 53300 1American Association for Homecare Supports Crackdown on Medicare Scammers in Houston Boston New York Louisiana 53300 2American Association for Homecare Supports Crackdown on Medicare Scammers in Houston Boston New York Louisiana 53300 3American Association for Homecare Supports Crackdown on Medicare Scammers in Houston Boston New York Louisiana 53300 4Detroit Branch NAACP President Rev Dr Wendell Anthony Denounces Congressman Thaddeus McCotters Resolution 53296 1
Other Contentsbiophysicsbiophysicsbiopolymerbiopolymerblastblastcountcountcountcountcountcountcountfullfullfullfullfullfullfullfullfullfullbotanybotanybrainbrainbrainbrainbrainbrainbrainbrainbrainbrain